The ARK Innovation ETF (ARKK) has reported an approximate $117.8 million outflow, marking a 1.9% decrease in shares outstanding, dropping from 88.4 million to 86.7 million this week. This change highlights investor shifts as the fund’s assets continue to fluctuate amidst the volatile market conditions.
Notably, key holdings in ARKK experienced varied performance, with CRISPR Therapeutics AG (CRSP) up by 2.9%, Tempus AI Inc (TEM) increasing by 5.6%, and Robinhood Markets Inc (HOOD) rising by 2.2%. As of the latest trading data, ARKK’s share price was $71.18, with a 52-week range between $43.68 and $92.65.
For additional context, analyzing the ETF in relation to its 200-day moving average can provide investors with insights into its price trends and overall market positions.
